This non-interventional study seeks to understand patients' perspectives around the decision to take part in a clinical trial for a hemophilia therapy. Data are collected through qualitative interviews with participants/patients and with investigators and study coordinators. To take part, individuals must have been screened and consented for the AskBio009-101 study, speak and understand English, be between 18 and 75 years old, and be physically able to complete a one-hour phone interview.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion criteria for patients: * Were screened and consented for the AskBio009-101study at any point in time * Are able to speak and understand English * Are between ages of 18 and 75 * Are physically able to participate in a one-hour phone interview * Consented into this study independently of the AskBio009-101 study Exclusion criteria for patients: \- N/A Inclusion criteria for investigators and coordinators: * Worked at a site as an investigator or study coordinator that consented a patient into the * AskBio009-101 trial at any point in time, including those that no longer work at a AskBio009-101 site * Are able to speak and understand English * Are between ages of 18 and 75 * Are physically able to participate in a one-hour phone interview Exclusion criteria for investigators and coordinators: \- Not directly involved in the consent process at the gene therapy site